Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells

Nutrition and Cancer

Volumn 68, Issue 5, 2016, Pages 873-877

  Fogli, Stefano ^a   Arena, Chiara ^a   Carpi, Sara ^a   Polini, Beatrice ^a   Bertini, Simone ^a   Digiacomo, Maria ^a   Gado, Francesca ^a   Saba, Alessandro ^a   Saccomanni, Giuseppe ^a   Breschi, Maria Cristina ^a   Nieri, Paola ^a   Manera, Clementina ^a   Macchia, Marco ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OLEOCANTHAL; PHENOL DERIVATIVE; PROTEIN BCL 2; PROTEIN KINASE B; UNCLASSIFIED DRUG; VIRGIN OLIVE OIL; ALDEHYDE; BCL2 PROTEIN, HUMAN; OLIVE OIL; ONCOPROTEIN;

ANTIPROLIFERATIVE ACTIVITY; CELL VIABILITY; CYTOTOXICITY; DOWN REGULATION; DRUG ISOLATION; DRUG PURIFICATION; EXTRACTION; FIBROBLAST; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; MELANOMA CELL; NOTE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WST-1 ASSAY; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GENETICS; MAPK SIGNALING; MELANOMA; METABOLISM; SKIN TUMOR; TUMOR CELL LINE;

ALDEHYDES; CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; HUMANS; INHIBITORY CONCENTRATION 50; MAP KINASE SIGNALING SYSTEM; MELANOMA; OLIVE OIL; ONCOGENE PROTEIN V-AKT; PHENOLS; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN NEOPLASMS;

EID: 84973659366     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2016.1180407     Document Type: Note

References (20)

1. J.Delyon, M.Maio, and C.Lebbé: The ipilimumab lesson in melanoma: Achieving long-term survival. Semin Oncol 42, 387–401, 2015. doi:10.1053/j.seminoncol.2015.02.005
2. R.Danielli, R.Patuzzo, A.M.Di Giacomo, G.Gallino, A.Maurichi, A.Di Florio, et al.: Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study. Cancer Immunol Immunother 1–11, 2015. doi:10.1007/s00262-015-1704-6
3. G.K.Beauchamp, R.S.J.Keast, D.Morel, J.Lin, J.Pika, Q.Han, et al.: Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature 437, 45–46, 2005. doi:10.1038/437045a
4. L.Parkinson and R.Keast: Oleocanthal, a phenolic derived from virgin olive oil: a review of the beneficial effects on inflammatory disease. Int J Mol Sci 15, 12323–12334, 2014. doi:10.3390/ijms150712323
5. S.Carpi, S.Fogli, A.Giannetti, B.Adinolfi, S.Tombelli, E.Da Pozzo, et al.: Theranostic properties of a survivin-directed molecular beacon in human melanoma cells. PLoS ONE 9, e114588, 2014. doi:10.1371/journal.pone.0114588
6. D.M.Su, Q.Zhang, X.Wang, P.He, Y.J.Zhu, J.Zhao, et al.: Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy. Mol Cancer Ther 8, 1292–1304, 2009. doi:10.1158/1535-7163.MCT-08-1030
7. R.Halaban, W.Zhang, A.Bacchiocchi, E.Cheng, F.Parisi, S.Ariyan, et al.: PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells. Pigment Cell Melanoma Res 23, 190–200, 2010. doi:10.1111/j.1755-148X.2010.00685.x
8. I.Arozarena, B.Sanchez-Laorden, L.Packer, C.Hidalgo-Carcedo, R.Hayward, A.Viros, et al.: Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A. Cancer Cell 19, 45–57, 2011. doi:10.1016/j.ccr.2010.10.029
9. M.R.Akl, N.M.Ayoub, M.M.Mohyeldin, B.A.Busnena, A.I.Foudah, Y.-Y.Liu, et al.: Olive phenolics as c-Met inhibitors: (−)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models. PLoS ONE 9, e97622, 2014. doi:10.1371/journal.pone.0097622
10. O.LeGendre, P.A.S.Breslin, and D.A.Foster: (−)-Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilization (LMP). Mol Cell Oncol 2(4), e1006077, 2015. doi:10.1080/23723556.2015.1006077
11. T.Oltersdorf, S.W.Elmore, A.R.Shoemaker, R.C.Armstrong, D.J.Augeri, B.A.Belli, et al.: An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435, 677–681, 2005. doi:10.1038/nature03579
12. M.N.Serasinghe, D.J.Missert, J.J.Asciolla, S.Podgrabinska, S.Y.Wieder, S.Izadmehr, et al.: Anti-apoptotic BCL-2 proteins govern cellular outcome following B-RAF(V600E) inhibition and can be targeted to reduce resistance. Oncogene 34, 857–867, 2015. doi:10.1038/onc.2014.21
13. M.Scotece, R.Gomez, J.Conde, V.Lopez, J.J.Gomez-Reino, F.Lago, et al.: Oleocanthal inhibits proliferation and MIP-1α expression in human multiple myeloma cells. Curr Med Chem 20(19), 2467–2475, 2013.
14. H.E.Haarberg and K.S.M.Smalley: Resistance to Raf inhibition in cancer. Drug Discov Today Technol 11, 27–32, 2014. doi:10.1016/j.ddtec.2013.12.004
15. H.-H.Cao, C.-Y.Cheng, T.Su, X.-Q.Fu, H.Guo, T.Li, et al.: Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion. Mol Cancer 14, 1–12, 2015. doi:10.1186/s12943-015-0367-4
16. L.Gao, Y.Feng, R.Bowers, M.Becker-Hapak, J.Gardner, L.Council, et al.: Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis. Cancer Res 66, 7880–7888, 2006. doi:10.1158/0008-5472.CAN-06-0254
17. P.C.Ma, M.S.Tretiakova, V.Nallasura, R.Jagadeeswaran, A.N.Husain, and R.Salgia: Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion. Br J Cancer 97, 368–77, 2007. doi:10.1038/sj.bjc.6603884
18. B.A.Busnena, A.I.Foudah, T.Melancon, and K.A.Sayed El: Olive secoiridoids and semisynthetic bioisostere analogues for the control of metastatic breast cancer. Bioorg Med Chem 21, 2117–2127, 2013. doi:10.1016/j.bmc.2012.12.050
19. S.Carpi, S.Fogli, A.Romanini, M.Pellegrino, B.Adinolfi, P.APodestà, et al.: AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells. Anticancer Drugs 2015;Publish Ahead of Print:1. doi:10.1097/CAD.0000000000000246
20. S.Grösch, T.J.Maier, S.Schiffmann, and G.Geisslinger: Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 98, 736–747, 2006. doi:10.1093/jnci/djj206